Optical low–coherence reflectometry useful for biometric measurements

Article

The Lenstar LS 900 and applanation ultrasound can be used interchangeably for biometric measurement in cataract patients

The Lenstar LS 900 and applanation ultrasound can be used interchangeably for biometric measurement in cataract patients, according to a study published in Graefe's Archive for Clinical and Experimental Ophthalmology.

A team led by Dr Damir Bosnar, University Eye Clinic, University Hospital Sveti Duh, Croatia, compared the innovative non-contact optical low-coherence reflectometry (OLCR) method by the Lenstar LS 900 with applanation ultrasound to see if there was sufficient agreement in results of biometric measurements for intraocular lens (IOL) power calculations to warrant a replacement method.

Five consecutive measurements were performed on 32 eyes of 22 cataract patients. Applanation ultrasound and Lenstar IOL power calculation was based on both their automated keratometry and axial length measurements. Interobserver repeatability of applanation ultrasound and Lenstar was assessed by Bland-Altman analysis.

Predicted refractive error in 95%of observations was 0.26 ± 0.62 D with applanation ultrasound and 0.01± 0.20 D with Lenstar. The Lenstar demonstrated excellent repeatability and the applanation ultrasound showed acceptable repeatability.

The study suggested that OLCR could become an alternative method for biometric measurement for IOL power calculation in cataract patients.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.